Presentation of protective antigen to the mouse immune system: immune sequelae
Open Access
- 1 August 1999
- journal article
- research article
- Published by Wiley in Journal of Applied Microbiology
- Vol. 87 (2) , 315-317
- https://doi.org/10.1046/j.1365-2672.1999.00901.x
Abstract
Protective antigen (PA), the major protective component of the existing vaccine, is a potent immunogen. Protective antigen in alhydrogel induced a high serum IgG titre (> log10 4) in both the C57B16 and Balb/c mouse and the predominant subclass of antibody induced was IgG1, indicating that the response to PA was predominantly Th2 directed. When plasmid DNA encoding PA was used to immunize the Balb/c mouse, a low serum IgG titre was detected (≤log10 1), which was slightly increased by boosting with plasmid DNA. However, when mice immunized with plasmid DNA were later boosted with rPA, a significant and rapid increase in titre (up to threefold) was observed. Priming mice with PA‐encoding plasmid DNA may be a mechanism of enhancing and accelerating the immune response to PA.Keywords
This publication has 5 references indexed in Scilit:
- Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracisLetters in Applied Microbiology, 1998
- Gene vaccination with naked plasmid DNA: mechanism of CTL priming.The Journal of Experimental Medicine, 1996
- DNA-based immunization against the envelope proteins of the hepatitis B virusJournal of Biotechnology, 1996
- Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses.Proceedings of the National Academy of Sciences, 1994
- A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangreneVaccine, 1993